INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. FILES APPLICATION FOR "USE OF DNA-PK INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS IN COMBINATION WITH RADIOTHERAPY"

GENEVA, Feb. 3 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (4th Floor, Building 2, No. 319, Tsingtao Brewery AvenueWenjiang DistrictChengdu City, Sichuan) filed a patent application (PCT/IB2025/057491) for "USE OF DNA-PK INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS IN COMBINATION WITH RADIOTHERAPY" on Jul 24, 2025. With publication no. WO/2026/022745, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEI, Yonggang (c/o KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD.4th Floor, Building 2, No. 319, Tsingtao Brewery...